BackBalaji Amines Limited Overview

Balaji Amines Limited EBIT

Latest ebit for BALAMINES.NS: $3.3B, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$862.63M
↑ 64.03% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$3.29B
↑ 65.69% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Balaji Amines Limited (BALAMINES.NS) FAQ

The latest EBIT for BALAMINES.NS is $3.3B as of September 2026. That compares with $2B in the prior-year period — up 65.7% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Balaji Amines Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BALAMINES.NS's EBIT moved from $2B to $3.3B — a 65.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Balaji Amines Limited's operating scale or balance-sheet position.

Against its sector companies, BALAMINES.NS currently prints $3.3B for EBIT, while the sector average sits near $2.4T. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Balaji Amines Limited's growth, margins, and balance sheet.

A EBIT figure of $3.3B for BALAMINES.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting BALAMINES.NS's EBIT ($3.3B), review year-over-year change from $2B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.